2021
DOI: 10.1097/icl.0000000000000792
|View full text |Cite
|
Sign up to set email alerts
|

Irregular Astigmatism Management Using SPOT Scleral Lenses in the Treatment of Corneal Ectasia and Penetrating Keratoplasty

Abstract: To evaluate the outcome of SPOT scleral lenses in the management of irregular astigmatism in patients with corneal ectasia and penetrating keratoplasty. Second, we analyzed patients' characteristics and tolerance, comfort, and geometries of fitted lenses. Method: Over a 5-year period, we included patients experiencing irregular astigmatism fitted with SPOT scleral contact lenses, from the University Hospital of Clermont-Ferrand, France. Data collected included corneal diseases, refractive error, best-corrected… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
11
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(12 citation statements)
references
References 34 publications
0
11
0
Order By: Relevance
“…16 In fact, they were considered the gold standard for patients with advanced KC, 16–18 but numerous studies reported the benefits of SL versus RGPCL for advanced corneal irregularities, achieving greater comfort, centration, stability, and providing good VA and long-term safety and efficacy. 19–25 The latter is discussed by Fuller et al showing an excellent long-term safety and efficacy of SL in the visual rehabilitation in subjects with KC, therefore achieving an improvement in VA. 21 Cagliari et al 22 also evaluated safety and highlighted that the daily use of SL in KC patients was not associated with adverse effects on the cornea or endothelium over a 90-day period and they did not find a progression of the disease. Vincent et al 25 stated that SL may provide exceptional VA outcomes in patients with complex corneal shapes that otherwise would not be achieved with a smaller diameter rigid lens.…”
Section: Discussionmentioning
confidence: 98%
See 3 more Smart Citations
“…16 In fact, they were considered the gold standard for patients with advanced KC, 16–18 but numerous studies reported the benefits of SL versus RGPCL for advanced corneal irregularities, achieving greater comfort, centration, stability, and providing good VA and long-term safety and efficacy. 19–25 The latter is discussed by Fuller et al showing an excellent long-term safety and efficacy of SL in the visual rehabilitation in subjects with KC, therefore achieving an improvement in VA. 21 Cagliari et al 22 also evaluated safety and highlighted that the daily use of SL in KC patients was not associated with adverse effects on the cornea or endothelium over a 90-day period and they did not find a progression of the disease. Vincent et al 25 stated that SL may provide exceptional VA outcomes in patients with complex corneal shapes that otherwise would not be achieved with a smaller diameter rigid lens.…”
Section: Discussionmentioning
confidence: 98%
“…37 Navel et al reported similar outcomes. 24 Although not included in the results of this review, there are also some case reports, such as the one published by Kumar et al that support this position. 37…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Scleral lenses (SLs) are currently prescribed primarily for management of corneal irregularity and ocular surface disease. They have been shown to improve visual acuity for patients with corneal ectasias because of keratoconus, 1–5 pellucid marginal degeneration 6 and keratoglobus 7 and patients with a history of previous ocular surgery 8–13 or trauma. 14,15 In addition, SLs have been shown to improve patient comfort and maintain ocular surface integrity in patients with moderate-to-severe ocular surface disease, 16–18 chronic graft-versus-host disease, 19–21 and Stevens Johnson syndrome.…”
mentioning
confidence: 99%